P68 Cost-Effectiveness of Ofatumumab in Comparison with Teriflunomide for Relapsing Multiple Sclerosis Treatment in China: From Both Healthcare System and Societal Perspectives
Abstract
Authors
H. Li Y. Jia M. HU
H. Li Y. Jia M. HU
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now